The global transradial access devices market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the transradial access devices market is expected to register a CAGR of 7.5% during the forecast period of 2018–2023.
Transradial access devices are used in the catheterization procedure or endovascular procedure to perform the diagnosis and treatment of any form of the arterial disease. A transradial access device kit comprises numerous small components such as guidewires, catheters, sheaths and sheath introducers, and accessories such as needles and cannulas. Mostly these kits are used for diagnosing and treating cardiovascular diseases. According to a study conducted by the World Health Organization (WHO) in 2017, about 17 million people died annually due to cardiovascular diseases worldwide.
Key Players
Some of the key players in the global transradial access devices market are Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic Plc (Ireland), Merit Medical System, Inc. (US), Boston Scientific Corporation (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), OSCOR Inc. (US), and others.
Segmentation
The global transradial access devices market is segmented by product, application, disease area, and end-user.
Based on product, the global transradial access devices market is classified as catheters, guidewires, sheaths, and sheath introducers, accessories, and others. Catheters are further divided into cardiovascular catheters, specialty catheters, intravenous catheters, urinary catheters, and neurological catheters. Guidewires are further classified as solid guidewire and wrapped guidewire.
Based on application, the global transradial access devices market is classified as drug administration, fluid and nutrition administration, blood transfusion, and diagnostics and testing.
Based on disease area, the global transradial access devices market is classified as cardiovascular diseases, cancer, rheumatoid arthritis, ischemic stroke, endometriosis, and others.
Based on end-user, the global transradial access devices market is classified as hospitals, clinics, ambulatory care centers, and others.